Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Botting

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
British Journal of Pharmacology|December 25, 2008
Audio-visual teaching material used on courses for new Home Office LicenseesR M Botting, A A Tuffery
Thrombosis Research|November 1, 2003
The mechanism of action of aspirinJ R Vane, R M Botting
Journal of Lipid Mediators and Cell Signalling|February 1, 1994
Control of the circulation by vasoactive mediators from endothelial cellsJ R Vane, R M Botting
Mediators of Inflammation|January 1, 1996
Cyclooxygenase-2 and its regulation in inflammationY S Bakhle, R M Botting
International Journal of Clinical Practice|April 6, 2000
The future of NSAID therapy: selective COX-2 inhibitorsJ R Vane, R M Botting
Polish Journal of Pharmacology and Pharmacy|May 1, 1990
Endothelins: potent releasers of prostacyclin and EDRFR M Botting, J R Vane
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 1, 1995
New insights into the mode of action of anti-inflammatory drugsJ R Vane, R M Botting
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
A better understanding of anti-inflammatory drugs based on isoforms of cyclooxygenase (COX-1 and COX-2)J R Vane, R M Botting
International Journal of Tissue Reactions|January 1, 1992
The role of chemical mediators released by the endothelium in the control of the cardiovascular systemJ R Vane, R M Botting
The American Journal of Cardiology|January 19, 1995
Pharmacodynamic profile of prostacyclinJ R Vane, R M Botting
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
British Journal of Pharmacology|December 25, 2008
Audio-visual teaching material used on courses for new Home Office LicenseesR M Botting, A A Tuffery
Thrombosis Research|November 1, 2003
The mechanism of action of aspirinJ R Vane, R M Botting
Journal of Lipid Mediators and Cell Signalling|February 1, 1994
Control of the circulation by vasoactive mediators from endothelial cellsJ R Vane, R M Botting
Mediators of Inflammation|January 1, 1996
Cyclooxygenase-2 and its regulation in inflammationY S Bakhle, R M Botting
International Journal of Clinical Practice|April 6, 2000
The future of NSAID therapy: selective COX-2 inhibitorsJ R Vane, R M Botting
Polish Journal of Pharmacology and Pharmacy|May 1, 1990
Endothelins: potent releasers of prostacyclin and EDRFR M Botting, J R Vane
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 1, 1995
New insights into the mode of action of anti-inflammatory drugsJ R Vane, R M Botting
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
A better understanding of anti-inflammatory drugs based on isoforms of cyclooxygenase (COX-1 and COX-2)J R Vane, R M Botting
International Journal of Tissue Reactions|January 1, 1992
The role of chemical mediators released by the endothelium in the control of the cardiovascular systemJ R Vane, R M Botting
The American Journal of Cardiology|January 19, 1995
Pharmacodynamic profile of prostacyclinJ R Vane, R M Botting
Pageof 4